Evidence, regulation and 'rational' prescribing: The case of gabapentin for neuropathic pain

Journal of Evaluation in Clinical Practice

Volumn 21, Issue 1, 2015, Pages 28-33

  Ghinea, Narcyz ^a   Lipworth, Wendy ^b   Kerridge, Ian ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

chronic pain; doctor's practice patterns; drug industry; neuralgia; off label use; pain management

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DRUG INDICATION; DRUG INDUSTRY; DRUG MARKETING; DRUG USE; EPIDEMIOLOGICAL DATA; HUMAN; LEGAL LIABILITY; NEUROPATHIC PAIN; OFF LABEL DRUG USE; PRESCRIPTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; NEURALGIA;

AMINES; ANALGESICS; ANTICONVULSANTS; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEURALGIA; OFF-LABEL USE; PRACTICE PATTERNS, PHYSICIANS';

EID: 84923689417     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12223     Document Type: Article

References (53)

1. Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., &, Richardson, W. R., (1996) Evidence based medicine: what it is an what it isn't. British Medical Journal, 312, 71.
2. Gulmezoglu, A. M., Chandler, J., Sheppard, S., &, Pantoja, T., (2013) Reviews of qualitative evidence: a new milestone for Cochrane. Cochrane Database of Systematic Reviews, (11), CD000073.
3. Charlton, B. G., (1997) Restoring the balance: evidence-based medicine put in its place. Journal of Evaluation in Clinical Practice, 3, 87-98.
4. Fricker, M., (2007) Epistemic Injustice: Power and the Ethics of Knowing. New York: Oxford University Press.
5. Genius, S. J., (2004) Resisting cookbook medicine. British Medical Journal, 329, 179.1.
6. Moayyedi, P., (2008) CON: evidence-based medicine-the emperor's new clothes? The American Journal of Gastroenterology, 103, 2968-2969.
7. Leger-Riopel, N., (2013) Medical liability in an era of evidence-based medicine. Bucerius Law Journal, 2013, 26-32. Available at: http://law-journal.de/en/archive/volume-2013/issue-1/medical-liability-in-An-era-of-evidence-based-medicine/ (last accessed 24 June 2014).
8. McNutt, R. A., &, Livingston, E. H., (2010) Evidence-based medicine requires appropriate clinical context. Journal of the American Medical Association, 303, 454-455.
9. Chen, H., Deshpande, A. D., Jiang, R., &, Martin, B. C., (2005) An epidemiological investigation of off-label anticonvulsant drug use in the Georgia Medicaid population. Pharmacoepidemiology and Drug Safety, 14, 629-639.
10. Rosner, H., Rubin, L., &, Kestenbaum, A., (1996) Gabapentin adjunctive therapy in neuropathic pain states. The Clinical Journal of Pain, 12, 56-58.
11. Backonja, M., Beydoun, A., Edwards, K. R., Schwartz, S. L., Fonesca, V., Hes, M., LaMoreaux, L., &, Garofalo, E., (1998) Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Journal of the American Medical Association, 280, 1831-1836.
12. Rowbotham, M., Harden, N., Stacey, B., Bernstein, P., &, Magnus-Miller, L., (1998) Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. Journal of the American Medical Association, 280, 1837-1842.
13. Wiffen, P., Collins, S., McQuay, H., Carroll, D., Jadad, A., &, Moore, A., (2000) Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reveiws, (3), CD001133.
14. Wiffen, P. J., McQuay, H. J., Edwards, J. E., &, Moore, R. A., (2005) Gabapentin for acute and chronic pain. Cochrane Database of Systematic Reviews, (3), CD005452.
15. US Department of Justice (2004) Warner-Lambert to pay $430 million to resolve criminal & civil health care liability relating to off-label promotion. Department of Justice website. Available at: http://www.justice.gov/opa/pr/2004/May/04-civ-322.htm. (last accessed 6 April 2014).
16. Vedula, S. S., Bero, L. A., Scherer, R. W., &, Dickerson, K., (2009) Outcome reporting in industry-sponsored trials of gabapentin for off-label use. New England Journal of Medicine, 361, 1963-1971.
17. Chaparro, L. E., Smith, S. A., Moore, R. A., Wiffen, P. J., &, Gilron, I., (2013) Pharmacotherapy for the prevention of chronic pain after surgery in adults. Cochrane Database of Systematic Reviews, (7), CD008307.
18. Therapeutics Initiative (2009) Gabapentin for pain: new evidence from hidden data. Therapeutics Letter, Newsletter #75. Available at: www.ti.ubc.ca/es/letter75 (last accessed 6 April 2014).
19. Moore, R. A., Wiffen, P. J., &, McQuay, H. J., (2011) Gabapentin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, (3), CD007938.
20. Straube, S., Derry, S., Moore, R. A., Wiffen, P. J., &, McQuay, H. J., (2010) Single dose oral gabapentin for established acute postoperative pain in adults. Cochrane Database of Systematic Reviews, (5), CD008183.
21. Lam, W., (2003) Off-label promotion and prescribing of gabapentin. Australian Prescriber, 26, 28.
22. United States District Court District of Massachusetts (2010) In re Neurontin Marketing and Sales Practices Litigation, Civil Action No. 04-cv-10739-PBS. Available at: http://pacer.mad.uscourts.gov/dc/cgi-bin/recentops.pl?filename=saris/pdf/ucl%20opinion.pdf (last accessed 6 April 2014).
23. Spence, D., (2013) Bad medicine: gabapentin and pregabalin-response from author. British Medical Journal, 347, f6747.
24. Health and Social Care Information Centre (2012) Prescription cost analysis England. Available at: https://catalogue.ic.nhs.uk/publications/prescribing/primary/pres-cost-Anal-eng-2012/pres-cost-Anal-eng-2012a-rep.pdf (last accessed 6 April 2014).
25. Dworkin, R. H., O'Connor, A. B., Audette, J., et al. (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clinic Proceedings, 85, S3-S14.
26. Shenfield, G., (2012) Your questions to the PBAC: gabapentin. Australian Prescriber, 36, 82.
27. Morse, J. M., (1994) 'Emerging from the data': The cognitive processes of analysis in qualitative inquiry. In Critical Issues in Qualitative Research Methods (ed., J. M. Morse,), pp. 23-42. Thousand Oaks: Sage.
28. Charmaz, K., (2006) Constructing Grounded Theory: A Practical Guide through Qualitative Analysis. London: Sage.
29. Mercadante, S., (2002) Gabapentin in painful ophthalmoplegia. Journal of Pain Symptom Management, 24, 288-289.
30. Jensen, T. S., &, Finnerup, N. B., (2009) Neuropathic pain treatment: a further step forward. Lancet, 374, 1218-1219.
31. Klass, M., &, Csete, M., (2008) One from column A and one from column B: may I take your order? Anesthesiology, 109, 165-166.
32. Gehling, M., &, Tryba, M., (2002) Comment on Rice ASC, Maton S, the Postherpetic Neuralgia Study Group (UK), Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo-controlled study, Pain 2001;94:215-224. Pain, 96, 410-411.
33. Serpell, M. G., & Neuropathic Pain Study Group (2002) Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain, 99, 557-566.
34. McCleane, G. J., (2003) Comment on: Serpell et al., gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo controlled trial (Pain 2002; 99: 557-66). Pain, 103, 227.
35. Clendenen, S. R., &, Harrison, B. A., (2007) Single-dose gabapentin does not augment postoperative analgesia in ambulatory arthroscopic shoulder surgery. Anesthesia & Analgesia, 105, 280-281.
36. Caraceni, A., Zecca, E., Martini, C., &, De Conno, F., (2001) Differences in gabapentin efficacy for cancer pain more apparent than real? Journal of Pain Symptom Management, 21, 93-94.
37. McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P., &, Moore, A., (1995) Anticonvulsant drugs for management of pain: a systematic review. British Medical Journal, 311, 1047-1052.
38. Adam, F., Sessler, D. I., &, Chauvin, M., (2007) Single-dose gabapentin does not augment postoperative analgesia in ambulatory arthroscopic shoulder surgery. Anesthesia & Analgesia, 105, 281.
39. Buvanendran, A., (2012) Chronic postsurgical pain: are we closer to understanding the puzzle. Anesthesia & Analgesia, 115, 231-232.
40. Kumar, A., &, Tyagi, A., (2009) Dixon and Massey's method: the starting dose. Anesthesia & Analgesia, 108, 378.
41. Ross, J. R., Waight, C., Riley, J. B., &, Broadley, K., (2001) Gabapentin: resistant neuropathic pain and malignancy. Palliative Medine, 15, 348-349.
42. Gilron, I., (2003) Gabapentin: a viewpoint by Ian Gilron. CNS Drugs, 17, 983-984.
43. Dubey, P. K., (2008) Gabapentin for the treatment of glossodynia due to an unusual cause. Anesthesia & Analgesia, 107, 729.
44. Nguyen, V. H., &, Lawrence, H. J., (2004) Use of gabapentin in the prevention of taxane-induced arthralgias and myalgias. Journal of Clinical Oncology, 22, 1767-1769.
45. van Deventer, H., &, Bernard, S., (1999) Use of gabapentin to treat taxane-induced myalgias. Journal of Clinical Oncology, 17, 434-435.
46. Phillips, C. J., (2009) The cost and burden of chronic pain. British Journal of Pain, 3, 2-5.
47. Gaskin, D. J., &, Richard, P., (2012) The economic costs of pain in the United States. The Journal of Pain, 13, 715-724.
48. Goldberg, D. S., &, McGee, S. J., (2011) Pain as a global public health priority. BMC Public Health, 11, 770.
49. McQuay, H., (2008) Help and hope at the bottom of the pile. British Medical Journal, 336, 954-955.
50. Motov, S. M., &, Khan, A., (2009) Problems and barriers of pain management in the emergency department: are we ever going to get better? Journal of Pain Research, 2, 5-11.
51. Finnerup, N. B., Otto, M., McQuay, H., Jensen, T. S., &, Sindrup, S. H., (2005) Algorithm for neuropathic pain treatment: an evidence based proposal. Pain, 118, 289-305.
52. Ravetz, J., (2004) The post-normal science of precaution. Futures, 36, 347-357.
53. US National Institutes of Health (2014) History, policies, and laws. Clinicaltrials.gov website. Available at: http://www.clinicaltrials.gov/ct2/about-site/history (last accessed 6 April 2014).